You have 7 free searches left this month | for more free features.

Progression-free survival

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Independent Living, Disability Free Survival, Elderly Trial in Australia (Atorvastatin, Placebo (for Atorvastatin))

Recruiting
  • Independent Living
  • +3 more
  • Hobart, Tasmania, Australia
  • +5 more
Nov 28, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Myrtle Beach (Darolutamide, Enzalutamide, Radium-223)

Terminated
  • Metastatic Castration-resistant Prostate Cancer
  • Enzalutamide during Lead-in Period
  • +5 more
  • Myrtle Beach, South Carolina
    Research Site
Sep 9, 2022

OBSERVATIONAL STUDY OF AVELUMAB AS FIRST-LINE MAINTENANCE

Recruiting
  • Urothelial Cancer
  • Bristol, United Kingdom
  • +9 more
Jan 23, 2023

Surgical Complications and DFS in Obese Rectal Cancer Patients

Recruiting
  • Obesity, Morbid
  • +2 more
  • BIB positioning
  • Naples, Italy
    Nunzio Velotti
Sep 27, 2023

Liver Metastasis, Colon Cancer Trial in United Kingdom (Icosapent Ethyl, Placebo)

Recruiting
  • Liver Metastasis
  • Colon Cancer
  • Icosapent Ethyl
  • Placebo
  • Oxford, Oxfordshire, United Kingdom
  • +12 more
Nov 7, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Netherlands

Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
    • Alkmaar, Netherlands
    • +27 more
    Jun 27, 2023

    Immunotherapy-related CRP Kinetics in Early and Metastatic

    Recruiting
    • TNBC - Triple-Negative Breast Cancer
      • Tuebingen, Germany
        Department of Women's Health
      Jun 13, 2023

      Dose Dense Chemotherapy in Elderly Patients > 80 Years Old With

      Completed
      • DLBCL
      • Old Age; Debility
        • Homburg, Saarland, Germany
          Saarland University Medical Center
        Nov 20, 2023

        Esophageal Cancer Trial in Shanghai (Propofol-based total intravenous anesthesia, Sevoflurane intravenous anesthesia)

        Recruiting
        • Esophageal Cancer
        • Propofol-based total intravenous anesthesia
        • Sevoflurane intravenous anesthesia
        • Shanghai, China
          Shanhai Chest Hospital
        Aug 26, 2021

        Can Second Resection for pT1 Bladder Cancer be Avoided After

        Recruiting
        • Bladder Cancer Stage I
        • Avoid second resection after initial complete resection
        • Mansoura, Dakahlia, Egypt
          Urology and nephrology center, Mansoura University
        Aug 2, 2023

        NSCLC Trial (Ivonescimab Injection, Pembrolizumab Injection)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • Ivonescimab Injection
        • Pembrolizumab Injection
        • (no location specified)
        Jun 9, 2023

        Non-Small-Cell Lung Carcinoma Trial in Hwasun (Nicotinamide)

        Unknown status
        • Non-Small-Cell Lung Carcinoma
        • Hwasun, Chonnam, Korea, Republic of
          Chonnam National University Hwasun Hospital
        Jan 23, 2020

        Immunotherapy-related CRP Kinetics in Metastatic Gynecological

        Recruiting
        • Gynecological Malignancies
        • +4 more
          • Tuebingen, Germany
            Department of Women's Health
          Jun 13, 2023

          Non-small Cell Lung Adenocarcinoma, Squamous Cell Carcinoma of Lung Trial in Guangzhou (SI-B001, Docetaxel)

          Not yet recruiting
          • Non-small Cell Lung Adenocarcinoma
          • Squamous Cell Carcinoma of Lung
          • Guangzhou, Guangdong, China
            Sun Yat-sen University Cancer Center
          Jul 5, 2023

          Immune Activation and Latent HIV Reservoir Size Between People

          Enrolling by invitation
          • HIV-1-infection
          • +3 more
          • Venipuncture
          • +4 more
          • Seattle, Washington
            University of Washington Positive Research and the Gastroenterol
          Oct 14, 2022

          SCCHN, Squamous Cell Carcinoma Trial in Birmingham (Cisplatin)

          Recruiting
          • SCCHN
          • Squamous Cell Carcinoma
          • Birmingham, Alabama
            University of Alabama at Birmingham
          Jan 5, 2023

          Cervical Cancer Trial (Nimotuzumab?Tislelizumab)

          Not yet recruiting
          • Cervical Cancer
          • (no location specified)
          Sep 9, 2023

          Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))

          Recruiting
          • Hepatocellular Carcinoma
          • Hangzhou, Zhejiang, China
            Guoliang Shao
          Aug 1, 2023

          Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial

          Recruiting
          • Glioma, Malignant
          • +6 more
          • Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
          • New York, New York
            Lenox Hill Brain Tumor Center
          Jul 13, 2023

          Disease-free Survival Trial in Shanghai (MBF-RIC)

          Recruiting
          • Disease-free Survival
          • Shanghai, Shanghai, China
          • +1 more
          Jun 28, 2022

          HER2-positive Breast Cancer, Breast Cancer, Breast Cancer Stage Trial in United States (Palbociclib, T-DM1)

          Completed
          • HER2-positive Breast Cancer
          • +5 more
          • Tucson, Arizona
          • +15 more
          Dec 22, 2022

          Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)

          Not yet recruiting
          • Oligometastatic Prostate Cancer
          • New York, New York
            Columbia University Irving Medical Center / NewYork-Presbyterian
          Jun 14, 2023

          T1 Squamous Cell Carcinomas of the Lip

          Active, not recruiting
          • Lip
          • +9 more
            • Nijmegen, Gelderland, Netherlands
            • +2 more
            Nov 2, 2022

            Liquid Biopsy in High-grade Gliomas and Meningiomas

            Recruiting
            • High Grade Glioma
            • High Grade Meningioma
              • Milano, MI, Italy
              • +4 more
              Nov 29, 2022